Showing 17,321 - 17,340 results of 20,793 for search '"therapy"', query time: 0.12s Refine Results
  1. 17321

    Outcomes of Surgical Treatment of Multiple Primary Colorectal and Prostate Cancer by I. S. Ignatov, V. V. Balaban, E. A. Bezrukov, A. V. Nikishina, M. He, P. V. Tsarkov

    Published 2025-02-01
    “…A clinician should be alert to multiple primary colorectal and prostate cancer. The first stage of therapy for the synchronous variant should be surgical treatment of colorectal cancer. …”
    Get full text
    Article
  2. 17322

    Dynamic Monitoring of sTREM-1 and Other Biomarkers in Acute Cholangitis by Jiahui Jiang, Xiaolei Wang, Tongtong Cheng, Mingyue Han, Xinxin Wu, Haitong Wan, DaojunYu

    Published 2020-01-01
    “…PCT alone is sufficient enough to diagnose sepsis with AC. sTREM-1 is the best biomarker to monitor patients’ response to antimicrobial therapy and biliary drainage.…”
    Get full text
    Article
  3. 17323

    A Machine Learning Approach Using Topic Modeling to Identify and Assess Experiences of Patients With Colorectal Cancer: Explorative Study by Kelly Voigt, Yingtao Sun, Ayush Patandin, Johanna Hendriks, Richard Hendrik Goossens, Cornelis Verhoef, Olga Husson, Dirk Grünhagen, Jiwon Jung

    Published 2025-01-01
    “…Dominant clusters included “Daily activities while living with CRC” (38,782, 18.3%) and “Understanding treatment including alternatives and adjuvant therapy” (31,577, 14.9%). Topics related to the home context had more emotional content compared with the hospital context. …”
    Get full text
    Article
  4. 17324

    Perceptions, Uses, and Information Sources of Medical Cannabis Among Patients With Cancer by Vera Qu, BA, Caressa Hui, MD, Jennifer Hall, BA, Kekoa Taparra, MD, PhD, Tanaya Kollipara, BA, Sandy Trieu, MD, Beth Beadle, MD, PhD, Scott Soltys, MD, Erqi L. Pollom, MD

    Published 2025-03-01
    “…Conclusions: Although most patients consider MC to be a valuable addition to conventional therapies for managing refractory symptoms, a subset believed it had potential as an anticancer therapy. …”
    Get full text
    Article
  5. 17325
  6. 17326

    Long-term mortality in patients with end-stage renal disease undergoing hemodialysis and peritoneal dialysis: a propensity score matching retrospective study by Pengjie Zhang, Liru Xun, Nan Bao, Ding Tong, Bin Duan, Du Peng

    Published 2024-12-01
    “…This study aimed to investigate the differences in survival and the factors that influence it in patients with end-stage renal disease treated with HD or PD.Methods We retrospectively analyzed factors related to all-cause death with renal replacement therapy and compared the long-term mortality between HD and PD strategies in patients with ESRD who started HD or PD treatment in our renal HD center between January 1, 2008, and December 1, 2021.Results Overall, 1,319 patients were included, comprising 690 and 629 patients in the HD and PD groups, respectively, according to the inclusion criteria. …”
    Get full text
    Article
  7. 17327

    Phylogenetic analysis and detection of positive selection in the SIRT gene family across vertebrates by Qiuxi Zhou, Xiongtao Yang, Da Li, Jing Li, Ling Peng, Wenwu He

    Published 2025-01-01
    “…Positively selected sites identified in this study may represent mutation hotspots, providing potential targets for future cancer therapy research.…”
    Get full text
    Article
  8. 17328

    Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention by Bin Que, Chunmei Wang, Hui Ai, Xinyong Zhang, Mei Wang, Shaoping Nie

    Published 2016-01-01
    “…A total of 3,047 ACS patients who underwent PCI and received statin therapy were included. Plasma concentrations of LDL-C, HDL-C, and TG were measured. …”
    Get full text
    Article
  9. 17329

    The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario by Haris M. Vaid, Ximena Camacho, John T. Granton, Muhammad M. Mamdani, Zhan Yao, Samantha Singh, David N. Juurlink, Tara Gomes

    Published 2016-01-01
    “…Overall mean age was 59.4 years (±20.3 years) and over 77% of cases were women (n=251). Combination therapy was used to treat 22.9% (n=69) of cases, costing an average of $4,569 (SD $1,544) per month. …”
    Get full text
    Article
  10. 17330
  11. 17331

    A Single Lung Transplant in a Patient with Fabry Disease: Causality or Far-Fetched? A Case Report by Martina Gaggl, Renate Kain, Peter Jaksch, Dominik Haider, Gerald Mundigler, Till Voigtländer, Raute Sunder-Plassmann, Paulus Rommer, Walter Klepetko, Gere Sunder-Plassmann

    Published 2013-01-01
    “…Overall, the patient might have benefited from specific enzyme replacement therapy, especially in view of the chronic kidney disease.…”
    Get full text
    Article
  12. 17332

    Liver GlucokinaseA456V Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase by Anna Vidal-Alabró, Alícia G. Gómez-Valadés, Andrés Méndez-Lucas, Jordi Llorens, Ramon Bartrons, Jordi Bermúdez, Jose C. Perales

    Published 2011-01-01
    “…Our results provide new insights into the complex GK regulatory network and validate liver-specific GK activation as a strategy for diabetes therapy.…”
    Get full text
    Article
  13. 17333

    Reduced irradiation exposure areas enhanced anti-tumor effect by inducing DNA damage and preserving lymphocytes by Huiqin Chen, Yuan Li, Qiaofeng Shen, Guanqun Guo, Zhigang Wang, Hanyu Pan, Min Wu, Xueqing Yan, Gen Yang

    Published 2024-12-01
    “…Abstract Background Partial stereotactic body radiation therapy (SBRT) targeting hypoxic regions of large tumors (SBRT-PATHY) has been shown to enhance the efficacy of tumor radiotherapy by harnessing the radiation-induced immune response. …”
    Get full text
    Article
  14. 17334

    Differences between SSRI and SNRI in depression treatment by Mateusz Grego, Katarzyna Grego, Łukasz Stojak, Dariusz Popiela, Karina Urbańska, Filip Kwiatkowski, Mateusz Baczewski, Witold Czyż

    Published 2025-01-01
    “…Conclusion The review of the literature and clinical trial results shows that no single universal group of medications can be identified for depression therapy. The choice should be tailored individually to each patient, taking into account the symptoms of their illness and the side effects of previously used medications. …”
    Get full text
    Article
  15. 17335

    Skin and Soft Tissue Infections in Patients with Solid Tumours by Diamantis P. Kofteridis, Antonios Valachis, Eirini Koutsounaki, Sofia Maraki, Eleni Mavrogeni, Foteini N. Economidou, Dimitra Dimopoulou, Kostas Kalbakis, Vassilis Georgoulias, George Samonis

    Published 2012-01-01
    “…All patients received antimicrobial therapy, while in 17 episodes (21%) an incision and drainage was required. …”
    Get full text
    Article
  16. 17336

    Early therapeutic efficacy of condoliase chemonucleolysis for lumbar disc herniation by Kazuyoshi Kobayashi, Koji Sato, Yoshinori Morita

    Published 2024-12-01
    “…This study was performed to identify the characteristics of early responders to condoliase therapy. Methods A retrospective cohort study was performed in 371 consecutive patients (259 males, 112 females; age, 49.9 ± 18.7 years; follow-up period, 13.1 ± 7.4 months) treated with condoliase injection for LDH between August 2018 and January 2024. …”
    Get full text
    Article
  17. 17337

    Major and minor perineural invasion in salivary gland cancer by Fei Liu, Yinglin Chu, Qizhe Zheng, Yunshuang Hu, Yiyi Wang, Lu Qin, Shuaikun Fu, Suping Wang

    Published 2025-01-01
    “…ObjectiveTo delineate the distribution of perineural invasion (PNI), evaluate its impact on patient survival, and identify optimal criteria for initiating adjuvant radiation therapy (RT) in cases of PNI associated with salivary gland cancer (SGC).MethodsThis retrospective study categorized enrolled patients into three groups based on PNI status (none, minor, or major), defined by the extent of nerve involvement. …”
    Get full text
    Article
  18. 17338
  19. 17339
  20. 17340

    Is Weight Loss the Main Driver for A1C Improvement by Glucagon‐Like Peptide 1 (GLP‐1) Receptor Agonists? A 2.5‐Year Analysis in Real‐World Clinical Practice by Marwa Al‐Badri, Shilton Dhaver, Osama Hamdy

    Published 2025-01-01
    “…Conclusions These findings suggest that the long‐term improvement in glycemic control associated with GLP‐1 RA therapy is primarily driven by weight loss rather than any other intrinsic effect of GLP‐1 RA. …”
    Get full text
    Article